Insider · CIK 0001189539

BRYSON VAUGHN D

Reports to the SEC for 6 companies · WILMINGTON, NC

sec.gov

Transactions

Companies

Filings

CIK

0001189539

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,095 sh	—	—	0
2011-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−1,139 sh	$33.25	−$37.9K	0
2011-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director	AAward	+9,095 sh	—	—	9,095
2011-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+1,139 sh	—	—	1,139
2007-06-29	ATHEROGENICS INCNon-qualified stock option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2007-03-06	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−12K sh	—	—	0
2007-03-06	AMYLIN PHARMACEUTICALS INCX Exercise of In-Money	Director	XExercise of In-Money	+12K sh	$22.89	+$275K	47,000
2007-01-29	ICOS CORPD Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$34.00	−$408K	0
2007-01-29	ICOS CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$11.14	−$134K	0
2006-06-30	ATHEROGENICS INCP Purchase	Director	PPurchase	+17.1K sh	$13.06	+$224K	169,832
2006-06-30	ATHEROGENICS INCP Purchase	Director	PPurchase	+17.1K sh	$13.06	+$224K	169,832
2006-06-29	ATHEROGENICS INCP Purchase	Director	PPurchase	+22.9K sh	$12.97	+$297K	152,700
2006-06-29	ATHEROGENICS INCP Purchase	Director	PPurchase	+22.9K sh	$12.97	+$297K	152,700
2006-05-30	ATHEROGENICS INCP Purchase	Director	PPurchase	+20K sh	$13.87	+$277K	129,832
2005-12-30	CHIRON CORPG Gift	Director	GGift	−2,318 sh	—	—	12,093
2005-12-30	CHIRON CORPD Disposition to Issuer	Director	DDisposition to Issuer	−2,800 sh	$44.50	−$125K	14,411
2005-07-01	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+460 sh	$21.12	+$9,715.2	3,980
2005-05-25	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)J Other	Director	JOther	+12K sh	—	—	12,000
2005-04-29	CHIRON CORPA Award	Director	AAward	+4,775 sh	—	—	17,221
2004-12-30	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+415 sh	$23.47	+$9,740.05	2,960
2004-10-01	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+465 sh	$20.97	+$9,751.05	2,545
2004-01-13	AMYLIN PHARMACEUTICALS INCX Exercise of In-Money	Director	XExercise of In-Money	+3,000 sh	$11.03	+$33.1K	11,000
2004-01-13	AMYLIN PHARMACEUTICALS INCX Exercise of In-Money	Director	XExercise of In-Money	+7,000 sh	$19.24	+$135K	18,000
2004-01-13	AMYLIN PHARMACEUTICALS INCX Exercise of In-Money	Director	XExercise of In-Money	+5,000 sh	$19.24	+$96.2K	23,000
2004-01-13	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−3,000 sh	—	—	0
2004-01-13	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−7,000 sh	—	—	5,000
2004-01-13	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−5,000 sh	—	—	0
2004-01-13	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+440 sh	$21.61	+$9,508.4	1,225
2003-10-16	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+345 sh	$28.51	+$9,835.95	785
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,467 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,208 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,352 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,926 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,432 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,562 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,360 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPD Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	$14.50	−$508K	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,875 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,242 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,562 sh	—	—	0
2003-07-08	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+440 sh	$22.52	+$9,908.8	440
2003-04-01	AMYLIN PHARMACEUTICALS INCPhantom Stock UnitsA Award	Director	AAward	+632 sh	$15.85	+$10K	8,182
2003-01-01	AMYLIN PHARMACEUTICALS INCPhantom Stock UnitsA Award	Director	AAward	+240 sh	$16.65	+$3,996	7,550
2002-09-16	QUINTILES TRANSNATIONAL CORPCommon StockD Disposition to Issuer	Director	DDisposition to Issuer	−4,467 sh	—	—	—
2002-09-16	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)A Award	Director	AAward	+4,467 sh	—	—	—
2002-07-01	AMYLIN PHARMACEUTICALS INCPhantom Stock UnitsA Award	Director	AAward	+234 sh	$9.60	+$2,246.4	7,070
2002-06-15	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)A Award	Director	AAward	+3,208 sh	—	—	—
2002-06-15	QUINTILES TRANSNATIONAL CORPCommon StockD Disposition to Issuer	Director	DDisposition to Issuer	−3,208 sh	—	—	—
2002-03-31	QUINTILES TRANSNATIONAL CORPCommon StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,352 sh	—	—	—
2002-03-31	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)A Award	Director	AAward	+2,352 sh	—	—	—

Recent filings

Accepted (ET)
Dec 64
BRYSON VAUGHN D0001189539-11-000003
SEC(opens sec.gov)
May 194
BRYSON VAUGHN D0001189539-11-000002
SEC(opens sec.gov)
Jul 24
ATHEROGENICS INC0001107601-07-000052
SEC(opens sec.gov)
Mar 74
AMYLIN PHARMACEUTICALS INC0001367982-07-000118
SEC(opens sec.gov)
Jan 304
ICOS CORP0001181431-07-006915
SEC(opens sec.gov)
Jul 34/A
ATHEROGENICS INC0001107601-06-000040
SEC(opens sec.gov)
Jul 34
ATHEROGENICS INC0001107601-06-000039
SEC(opens sec.gov)
May 314
ATHEROGENICS INC0001107601-06-000034
SEC(opens sec.gov)
Jan 44
CHIRON CORP0001300250-06-000005
SEC(opens sec.gov)
Jul 64
AMYLIN PHARMACEUTICALS INC0001264124-05-000200
SEC(opens sec.gov)
May 264
AMYLIN PHARMACEUTICALS INC0001264124-05-000166
SEC(opens sec.gov)
May 34
CHIRON CORP0001189539-05-000003
SEC(opens sec.gov)
Jan 34
BRYSON VAUGHN D0001264124-05-000012
SEC(opens sec.gov)

Companies

Address

929 NORTH FRONT STREET

WILMINGTON, NC, 28401